Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Tangible Net Worth Ratio

Latest as of September 2025: 97.5%

Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Tangible Net Worth Ratio of 97.5% as of September 2025. This metric is calculated by deducting intangible assets (CN¥340.39 Million) from net assets (CN¥13.86 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is Hubei Jumpcan Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

97.5%
Tangible equity / total equity

Net Assets (Equity)

CN¥13.86 Billion
CNY

Intangible Assets

CN¥340.39 Million
Goodwill, patents, brand value

Total Assets

CN¥16.53 Billion
CNY

Hubei Jumpcan Pharmaceutical Co Ltd Tangible Net Worth Ratio (1998–2024)

This chart shows how Hubei Jumpcan Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 27 annual periods from 1998 to 2024. As of September 2025, the ratio stands at 97.5%, reflecting net assets of CN¥13.86 Billion with intangible assets of CN¥340.39 Million CNY. See 600566 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Hubei Jumpcan Pharmaceutical Co Ltd (1998–2024)

The table below presents the year-by-year Tangible Net Worth Ratio for Hubei Jumpcan Pharmaceutical Co Ltd from 1998 to 2024, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Hubei Jumpcan Pharmaceutical Co Ltd stock valuation.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2024 97.9% CN¥14.73 Billion CN¥310.74 Million CN¥18.46 Billion ▲ +0.3 pp
2023 97.6% CN¥13.37 Billion CN¥315.70 Million CN¥18.14 Billion ▲ +0.5 pp
2022 97.2% CN¥11.35 Billion CN¥320.62 Million CN¥14.98 Billion ▲ +0.2 pp
2021 96.9% CN¥9.13 Billion CN¥280.04 Million CN¥12.13 Billion ▲ +0.6 pp
2020 96.3% CN¥7.76 Billion CN¥283.84 Million CN¥10.52 Billion ▲ +1.8 pp
2019 94.5% CN¥6.10 Billion CN¥335.83 Million CN¥8.66 Billion ▲ +0.4 pp
2018 94.1% CN¥5.46 Billion CN¥321.28 Million CN¥7.80 Billion ▼ -0.8 pp
2017 94.9% CN¥4.40 Billion CN¥222.59 Million CN¥6.66 Billion ▲ +1.1 pp
2016 93.9% CN¥3.69 Billion CN¥225.64 Million CN¥4.99 Billion ▲ +1.6 pp
2015 92.3% CN¥2.71 Billion CN¥209.78 Million CN¥3.59 Billion ▼ -1.6 pp
2014 93.8% CN¥2.29 Billion CN¥141.34 Million CN¥3.36 Billion ▲ +5.2 pp
2013 88.6% CN¥1.15 Billion CN¥131.27 Million CN¥2.01 Billion ▼ -6.3 pp
2012 94.9% CN¥490.80 Million CN¥25.16 Million CN¥992.87 Million ▼ -0.2 pp
2011 95.1% CN¥526.82 Million CN¥25.96 Million CN¥961.82 Million ▲ +0.2 pp
2010 94.9% CN¥520.27 Million CN¥26.76 Million CN¥863.16 Million ▲ +0.2 pp
2009 94.6% CN¥512.85 Million CN¥27.56 Million CN¥836.22 Million ▲ +0.0 pp
2008 94.6% CN¥506.18 Million CN¥27.34 Million CN¥829.61 Million ▲ +0.2 pp
2007 94.4% CN¥498.83 Million CN¥28.05 Million CN¥802.32 Million ▲ +7.8 pp
2006 86.6% CN¥485.82 Million CN¥65.29 Million CN¥786.51 Million ▲ +0.6 pp
2005 86.0% CN¥480.25 Million CN¥67.23 Million CN¥732.21 Million ▲ +0.6 pp
2004 85.4% CN¥473.92 Million CN¥69.17 Million CN¥697.90 Million ▲ +0.3 pp
2003 85.1% CN¥466.47 Million CN¥69.58 Million CN¥650.39 Million ▲ +0.7 pp
2002 84.4% CN¥459.05 Million CN¥71.49 Million CN¥607.22 Million ▼ -8.8 pp
2001 93.2% CN¥449.57 Million CN¥30.45 Million CN¥582.65 Million ▲ +14.5 pp
2000 78.7% CN¥140.01 Million CN¥29.78 Million CN¥223.38 Million ▲ +3.0 pp
1999 75.7% CN¥125.46 Million CN¥30.43 Million CN¥196.69 Million ▲ +4.4 pp
1998 71.3% CN¥108.44 Million CN¥31.08 Million CN¥186.23 Million
pp = percentage points